Market Place
(Sa)-Methyl 2-(benzyloxycarbonylamino) spiro[3.3]heptane-6- carboxylate
The quantity required is 1 kg / 10 kg / 20 kg lots.
Reply
Comments :
shailendra.rastgi@gvkbio.com
WE are interested in knowing more details.
Replyvijaya.nuty@gvkbio.com
GVK BIO offer long term Contract Manufacturing services right from strategic partnerships in development, validations, DMF filing and commercial manufacturing of Active Pharmaceutical Ingredients (APIs)/advanced intermediates to APIs
Our manufacturing facility has approvals from worldwide regulatory authorities like below and these accreditations facilitate faster and easier approvals of DMFs/dossiers for our business partners.
a) In rare instance a joint audit was performed by auditors from USFDA, EDQM and Spanish MOH in 2013.
b) We are approved by PMDA (Pharmaceutical and Medical Devices Agency) Japan in 2012 and supplying commercially to customers in Japan including Pfizer Japan.
c) FDA Korea approved us in 2012, we have our presence for a decade in Korea market and we serve to almost 8-9 OEMs.
USFDA in 2015 & 2018 (Received EIR)
Replytvkannan@molclonelabs.com
We can help you out regarding this. Please contact us at tvkannan@molclonelabs.com.
Replyinfo@molecraft.com
Dear sir, Please contact to us to develop and supply for the inquired compound. We have developed similar compounds in past for various MNCs. contact info@molecraft.com / 9885188881
Replyhebing@xacjoe.com
Xi'an Caijing supply CMO for pharmaceutical intermediates, please contact us at hebing@xacjoe.com
Replyankita.barve@piramal.com
We are interested in knowing more details.
Replychris@langhuapharma.com
Dear Sir or Madam,
We are USFDA/EDQM/WHO/CFDA/PMDA approved CDMO in China. With more than 15 years experience, we are supplying 5 intermeidates for current blockbuster drugs. We are interesting in your project and would like to contact to know more details.
Reply
Prev